C12N 5/0693
Tumour cells
Official title: {Tumour cells; Cancer cells}
C12N5/0693 (Tumour cells) appears on 1,012 US grants and 1,936 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,012
- Published applications
- 1,936
- Assignees
- 961
- Inventors
- 3,781
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 10 | 0 |
| 1995 | 2 | 0 |
| 1996 | 11 | 0 |
| 1997 | 11 | 0 |
| 1998 | 9 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 14 | 7 |
| 2002 | 13 | 16 |
| 2003 | 8 | 22 |
| 2004 | 11 | 20 |
| 2005 | 5 | 27 |
| 2006 | 11 | 22 |
| 2007 | 13 | 40 |
| 2008 | 10 | 42 |
| 2009 | 14 | 38 |
| 2010 | 24 | 51 |
| 2011 | 24 | 62 |
| 2012 | 31 | 75 |
| 2013 | 46 | 81 |
| 2014 | 47 | 80 |
| 2015 | 48 | 72 |
| 2016 | 39 | 93 |
| 2017 | 49 | 99 |
| 2018 | 68 | 113 |
| 2019 | 57 | 133 |
| 2020 | 57 | 126 |
| 2021 | 59 | 127 |
| 2022 | 64 | 144 |
| 2023 | 63 | 112 |
| 2024 | 60 | 148 |
| 2025 | 58 | 111 |
| 2026 | 38 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis6 Oct 2026US 12,753,384 B2Cornell Research Foundation, Inc.
- Liquid crystal scaffolds and use thereof for organoid, spheroid, and 3D cellaggregate manufacturing6 Oct 2026US 12,753,393 B2The Regents of the University of California
- Fas-associated factor 1 (FAF1)-loaded exosomes and use thereof as anti-cancer agent29 Sep 2026US 12,746,271 B2Kainos Medicine, Inc.
- Methods and systems for transportation and culture of buoyant tissue22 Sep 2026US 12,742,156 B2Keliomics, Inc.
- Filtration-based systems and methods for isolation of clustered particles15 Sep 2026US 12,735,681 B2Georgia Tech Research Corporation
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Click chemistry assisted cell surface engineering for restoring lentivirus entry8 Oct 2026US 2026/0308632 A1The Children’s Hospital of Philadelphia
- Microbe-gut-joint axis multi-organ chip and preparation method thereof1 Oct 2026US 2026/0297482 A1Center for Neuromusculoskeletal Restorative Medicine Limited
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Method to Form Microbial Biofilms on Functionalized Hydrogel Polymer Particles for Diagnostics and Cell Culture Applications24 Sep 2026US 2026/0286286 A1Ceres Nanosciences, Inc.
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Methods for preparing enriched human hematopoietic cell preparations128US 6,306,575 B1StemCell Technologies Inc. · 2001
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007
- Artificial antigen presenting cells and uses therefor105US 7,754,482 B2The Trustees of the University of Pennsylvania · 2010
- Antibody compositions for preparing enriched cell preparations104US 6,117,985 AStemCell Technologies Inc. · 2000